Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;15(1):23-7.
doi: 10.4103/0971-6866.50866.

Antiplatelet antibodies in cases of Glanzmann's thrombasthenia with and without a history of multiple platelet transfusion

Kanjaksha Ghosh  1 , B Kulkarni, S Shetty, S Nair
Affiliations

Antiplatelet antibodies in cases of Glanzmann's thrombasthenia with and without a history of multiple platelet transfusion

Kanjaksha Ghosh et al. Indian J Hum Genet. 2009 Jan.

Abstract

Antiplatelet antibodies are known to be present in a wide spectrum of patients, which include chronic Idiopathic Thrombocytopenic Purpura (ITP), infections, etc., including Glanzmann's thrombasthenia (GT) patients who receive multiple platelet transfusions. The presence of natural antibodies to platelet receptors is not studied in cases of GT. We studied the antiplatelet antibodies in 23 patients with GT, 15 of which had received multiple transfusions and eight that had not received transfusions, along with 50 cases of chronic ITP. The prevalence and specificity of platelet-bound antibodies were detected by inhibition assays using O-group platelets on flow cytometry. The mean antiplatelet antibodies in 15 patients of GT who had not received transfusions and eight patients with multiple transfusions was 8427 + 2131.88 and 9038 + 2856 antibodies/platelet, respectively, while in case of the 50 ITP patients studied, it was 22166 + 5616 antibodies/platelet (Normal Range 1500-3200 antibodies/platelet). We conclude that GT patients who have not received transfusions may develop antiplatelet antibodies to the missing/abnormal receptor. Whether this is due to a molecular mimicry or due to some other mechanism needs to be explored.

Keywords: Antiplatelet antibodies; Flow cytometry; Glanzmann's Thrombasthenia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Calibration curve for platelet antibodies by flow cytometry MAb Molec/platelet
See this image and copyright information in PMC

References

    1. Lee H, Nurden AT, Thomaidis A, Caen JP. Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann's thrombasthenia type 1 and type 2. Br J Haematol. 1981;48:47–57. - PubMed
    1. Kashyap R, Kriplani A, Saxena R, Takkar D, Choudhry VP. Pregnancy in a patient of Glanzmann's Thrombasthenia with anti-platelet antibodies. J Obstet Gynaecol Res. 1997;23:247–50. - PubMed
    1. Jallu V, Pico M, Chevaleyre J, Vezon G, Kunicki TJ, Nurden AT. Characterization of an antibody to the integrin beta 3 subunit (GP IIIa) from a patient with neonatal thrombocytopenia and an inherited deficiency of GP IIb- IIIa complexes in platelets (Glanzmann's thrombocytopenia) Hum Antibodies Hybridomas. 1992;3:93–106. - PubMed
    1. Kelton JG, Bussel JB. Idiopathic Immune thrombocytopenic purpura: An update. Semin Hematol. 2000;37:219–21. - PubMed
    1. Hagenstrom H, Schlenke P, Hennig H, Kirchner H, Kluter H. Quantification of platelet associated IgG for differential diagnosis of patients with thrombocytopenia. Thromb Haemost. 2000;84:779–83. - PubMed